Known targets — ChEMBL curated mechanism
POLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PRIM1PRIM2
The experimentally established mechanism targets of Cytidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.90 |
| ▸ | MTOR | P42345 | 2/20 | 0.90 |
| ▸ | THRB | P10828 | 1/20 | 0.90 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.90 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.90 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.90 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | GMNN | O75496 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.59 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.59 |
| ▸ | THPO | P40225 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | HBB | P68871 | 1/20 | 0.59 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.59 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.59 |
| ▸ | NT5E | P21589 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cytidine SCHEMBL1201153 | 1.00 | LMNA (0.90) | LMNAMTORTHRBMDM2NCOA1 | |
| Cytidine SCHEMBL376514 | 1.00 | LMNA (0.90) | LMNAMTORTHRBMDM2NCOA1 | |
| Cytarabine SCHEMBL28898416 | 1.00 | LMNA (0.90) | LMNAMTORTHRBMDM2NCOA1 | |
| Cytarabine SCHEMBL458337 | 1.00 | LMNA (0.90) | LMNAMTORTHRBMDM2NCOA1 | |
| Cytarabine SCHEMBL9007590 | 1.00 | LMNA (0.90) | LMNAMTORTHRBMDM2NCOA1 | |
| Cytidine SCHEMBL39902 | 1.00 | LMNA (0.90) | LMNAMTORTHRBMDM2NCOA1 | |
| Cytarabine SCHEMBL285195 | 1.00 | LMNA (0.90) | LMNAMTORTHRBMDM2NCOA1 | |
| Cytidine SCHEMBL6672407 | 0.99 | LMNA (0.88) | LMNAMTORTHRBMDM2NCOA1 | |
| Cytarabine SCHEMBL29084328 | 0.99 | LMNA (0.88) | LMNAMTORTHRBMDM2NCOA1 | |
| Cytidine SCHEMBL2370482 | 0.99 | LMNA (0.88) | LMNAMTORTHRBMDM2NCOA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5005 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260117271-A1 | SPECTRAL MONITORING OF IN VITRO TRANSCRIPTION | SANOFI PASTEUR INC (US) | 2026-04-30 | — | — | US | claimed |
| EP-4682514-A1 | METHOD FOR ANALYZING CELLS AND CELL-RELATED MATERIALS, AND SYSTEM | Live Cell Diagnosis, Ltd. (JP) | 2026-01-21 | — | — | EP | claimed |
| US-20250388944-A1 | IN VITRO TRANSCRIPTION TECHNOLOGIES | BioNTech SE (DE) | 2025-12-25 | — | — | US | claimed |
| US-12502431-B2 | Delivery and formulation of engineered nucleic acids | MODERNATX, INC. (US) | 2025-12-23 | — | — | US | claimed |
| US-20250378906-A1 | METHODS AND ARRANGEMENTS FOR INTERACTIVE SIMULATION OF XRNA PRODUCTION | ARRANTA BIO HOLDINGS LLC (US) | 2025-12-11 | — | — | US | claimed |
| US-20250369028-A1 | CONTINUOUS IN VITRO TRANSCRIPTION PROCESS AND APPARATUS | MODERNATX, INC. (US) | 2025-12-04 | — | — | US | claimed |
| US-12460259-B2 | Fed-batch in vitro transcription process | MODERNATX, INC. (US) | 2025-11-04 | — | — | US | claimed |
| US-20250275999-A1 | HIGH PURITY RNA COMPOSITIONS AND METHODS FOR PREPARATION THEREOF | MODERNATX, INC. (US) | 2025-09-04 | — | — | US | claimed |
| US-20250277180-A1 | APPARATUS, SYSTEMS AND METHODS FOR CONTINUOUS RNA MANUFACTURING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2025-09-04 | — | — | US | claimed |
| US-5405753-A | Reacting cytidine-5'-monophosphate with a neuraminic acid compound; then labeling with a fluorescent compound | BROSSMER, REINHARD | 1995-04-11 | — | — | US | claimed |
| EP-0447442-B1 | METHOD FOR POLYMERASE ACTIVITY DETERMINATION | KAELLANDER CLAS FREDRIK RUNESS (SE) | 1994-09-21 | — | — | EP | claimed |
| WO-1994016101-A2 | DNA SEQUENCING BY MASS SPECTROMETRY | KOESTER HUBERT (US) | 1994-07-21 | — | — | WO | claimed |
| EP-0447442-A1 | METHOD FOR POLYMERASE ACTIVITY DETERMINATION. | KAELLANDER CLAS FREDRIK RUNESS (SE) | 1991-09-25 | — | — | EP | claimed |
| WO-1990006320-A1 | SUBSTRATE FOR POLYMERASE ACTIVITY DETERMINATION | KAELLANDER CLAS FREDRIK RUNESS (SE) | 1990-06-14 | — | — | WO | claimed |
| WO-1990006373-A1 | METHOD FOR POLYMERASE ACTIVITY DETERMINATION | KAELLANDER CLAS FREDRIK RUNESS (SE) | 1990-06-14 | — | — | WO | claimed |
| WO-1988007854-A1 | NEW ANTI-RETROVIRAL AGENTS AND DELIVERY SYSTEM | UNITED STATES OF AMERICA, REPRESENTED BY THE UNITE (US) | 1988-10-20 | — | — | WO | claimed |
| EP-0286418-A1 | Anti-retroviral agents and delivery systems for the same | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1988-10-12 | — | — | EP | claimed |
| US-4704361-A | TRANSFERASE AND STABILIZERS | COMPAGNIA DI RICERCA CHIMICA S.P.A. (IT) | 1987-11-03 | — | — | US | claimed |
| EP-0120328-A2 | Pharmaceutical compositions containing the cytidine monophosphate of 5-acetamido-3,5-dideoxy-D-glycero-D-galactononulosaminic acid | C.R.C. Compagnia di Ricerca Chimica S.p.A. (IT) | 1984-10-03 | — | — | EP | claimed |